CN102617455B - Preparation method of pyridoxal or pyridoxal hydrochloride - Google Patents

Preparation method of pyridoxal or pyridoxal hydrochloride Download PDF

Info

Publication number
CN102617455B
CN102617455B CN201110442237.1A CN201110442237A CN102617455B CN 102617455 B CN102617455 B CN 102617455B CN 201110442237 A CN201110442237 A CN 201110442237A CN 102617455 B CN102617455 B CN 102617455B
Authority
CN
China
Prior art keywords
pyridoxal
hydrochloride
pyridoxine
preparation
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201110442237.1A
Other languages
Chinese (zh)
Other versions
CN102617455A (en
Inventor
施湘君
苏为科
陈巧巧
章根宝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi Tianxin Pharmaceutical Ltd By Share Ltd
Zhejiang University of Technology
Original Assignee
ZHEJIANG TIANXIN PHARMACEUTICAL CO Ltd
Zhejiang University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHEJIANG TIANXIN PHARMACEUTICAL CO Ltd, Zhejiang University of Technology filed Critical ZHEJIANG TIANXIN PHARMACEUTICAL CO Ltd
Priority to CN201110442237.1A priority Critical patent/CN102617455B/en
Publication of CN102617455A publication Critical patent/CN102617455A/en
Application granted granted Critical
Publication of CN102617455B publication Critical patent/CN102617455B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pyridine Compounds (AREA)

Abstract

本发明公开了一种吡哆醛或盐酸吡哆醛的制备方法,所述制备方法包括:以式(Ⅲ)所示的吡哆醇或盐酸吡哆醇为初始原料,以水为反应溶剂,所述的吡哆醇或盐酸吡哆醇在水中在催化氧化体系的作用下选择性氧化制得式(Ⅰ)所示的吡哆醛或盐酸吡哆醛;所述的催化氧化体系包括氧源、催化剂、无机盐和胺类配体。本发明的制备方法转化率高,选择性好,反应条件温和,操作方便,成本低廉,对环境友好,具有良好的工业化应用价值。 The invention discloses a preparation method of pyridoxal or pyridoxal hydrochloride. The preparation method comprises: using pyridoxine or pyridoxine hydrochloride represented by formula (III) as the initial raw material, using water as the reaction solvent, The pyridoxine or pyridoxine hydrochloride are selectively oxidized in water under the action of a catalytic oxidation system to prepare pyridoxal or pyridoxal hydrochloride shown in formula (I); the catalytic oxidation system includes an oxygen source , catalysts, inorganic salts and amine ligands. The preparation method of the invention has high conversion rate, good selectivity, mild reaction conditions, convenient operation, low cost, environmental friendliness and good industrial application value.

Description

一种吡哆醛或盐酸吡哆醛的制备方法A kind of preparation method of pyridoxal or pyridoxal hydrochloride

(一)技术领域(1) Technical field

本发明涉及一种吡哆醛或盐酸吡哆醛的制备方法,尤其是一种选择性氧化吡哆醇或盐酸吡哆醇制备吡哆醛或盐酸吡哆醛的方法。The invention relates to a method for preparing pyridoxal or pyridoxal hydrochloride, in particular to a method for selectively oxidizing pyridoxine or pyridoxine hydrochloride to prepare pyridoxal or pyridoxal hydrochloride.

(二)背景技术(2) Background technology

盐酸吡哆醛是维生素B6的一种衍生物,如式(Ⅰ)所示,是合成5-磷酸吡哆醛的关键中间体。5-磷酸吡哆醛化学名为2-甲基-3-羟基-4-甲醛-5-羟甲基吡啶磷酸酯,简称PLP,是维生素B6在细胞内经三磷酸腺苷激酶的作用下形成的一种活性成分,结构式如式(Ⅱ):Pyridoxal hydrochloride is a derivative of vitamin B6 , as shown in formula (I), it is a key intermediate for the synthesis of pyridoxal 5-phosphate. The chemical name of pyridoxal 5-phosphate is 2-methyl-3-hydroxy-4-formaldehyde-5-hydroxymethylpyridinium phosphate, referred to as PLP, which is a kind of vitamin B6 formed under the action of adenosine triphosphate kinase in cells. The active ingredient has a structural formula such as formula (II):

Figure BDA0000124941240000011
Figure BDA0000124941240000011

5-磷酸吡哆醛作为一个辅酶,能与体内100多个不同的酶作用,共同影响体内细胞的生化活动和新陈代谢。它是维持人体免疫系统正常必不可少的物质;是人体生长、发育、维持平衡的必备物质;是动物淀粉磷酸酯化的辅酶。除此之外,5-磷酸吡哆醛作为一个辅酶,还可辅助大脑细胞内神经胺的合成,加速受损大脑的恢复;辅助神经系统中神经纤维的髓鞘形成;辅助细胞叶酸代谢等。As a coenzyme, pyridoxal 5-phosphate can interact with more than 100 different enzymes in the body to jointly affect the biochemical activities and metabolism of cells in the body. It is an essential substance to maintain the normal immune system of the human body; it is an essential substance for the growth, development and maintenance of balance of the human body; it is a coenzyme for the phosphorylation of animal starch. In addition, pyridoxal 5-phosphate, as a coenzyme, can also assist the synthesis of neuroamine in brain cells, accelerate the recovery of damaged brains; assist the myelin formation of nerve fibers in the nervous system; assist cell folic acid metabolism, etc.

文献报道如下几种方法合成吡哆醛:Bibliography reports following several methods synthetic pyridoxal:

方法一,Ahens H;Korytnyk W.(J.Heterocycl.Chem.Vol.4,1967:625-626)报道了以盐酸吡哆醇为起始原料,用二氧化锰选择性氧化得到吡哆醛,收率77%。方法二,More Ashok.(Spectrochimica Acta Part A.Vol.72,2009:204-208)报道了以H2O2为氧化剂,二氯三(三苯基磷)钌复合物为催化剂选择性氧化吡哆醇为吡哆醛,收率96.66%。Method 1, Ahens H; Korytnyk W. (J.Heterocycl.Chem.Vol.4, 1967:625-626) reported that pyridoxine hydrochloride was used as a starting material, and pyridoxal was obtained by selective oxidation with manganese dioxide, Yield 77%. Method 2, More Ashok. (Spectrochimica Acta Part A.Vol.72, 2009: 204-208) reported the selective oxidation of pyrimidine with H 2 O 2 as oxidant and dichlorotris(triphenylphosphine) ruthenium complex as catalyst Pyridoxine is pyridoxal, and the yield is 96.66%.

上述两种方法均有不足之处,第一种方法使用二氧化锰为氧化剂,产生大量含锰废水,处理困难,对环境不友好;第二种不足之处使用过渡金属Ru,价格昂贵,目前尚无工业化应用价值,需要研究者们进一步开发。The above two methods have disadvantages. The first method uses manganese dioxide as an oxidant, which produces a large amount of manganese-containing wastewater, which is difficult to handle and is not environmentally friendly; the second method uses transition metal Ru, which is expensive and currently There is no industrial application value yet, and researchers need to further develop it.

(三)发明内容(3) Contents of the invention

为克服现有技术中反应污染大、过程复杂等缺点,本发明的目的是提供一种转化率高、选择性好、反应条件温和、操作方便、成本低廉、对环境友好、具有良好的工业化应用价值的选择性氧化吡哆醇或盐酸吡哆醇制备吡哆醛或盐酸吡哆醛的方法。In order to overcome the disadvantages of large reaction pollution and complicated process in the prior art, the purpose of the present invention is to provide a method with high conversion rate, good selectivity, mild reaction conditions, convenient operation, low cost, environmental friendliness and good industrial application The method for the selective oxidation of pyridoxine or pyridoxine hydrochloride to prepare pyridoxal or pyridoxal hydrochloride of value.

为实现上述发明目的,本发明采用如下技术方案:In order to realize the above-mentioned purpose of the invention, the present invention adopts following technical scheme:

一种吡哆醛或盐酸吡哆醛的制备方法,所述制备方法包括:以式(Ⅲ)所示的吡哆醇或盐酸吡哆醇为初始原料,以水为反应溶剂,所述的吡哆醇或盐酸吡哆醇在水中在催化氧化体系的作用下选择性氧化制得式(Ⅰ)所示的吡哆醛或盐酸吡哆醛;A kind of preparation method of pyridoxal or pyridoxal hydrochloride, described preparation method comprises: take pyridoxine or pyridoxine hydrochloride shown in formula (III) as initial raw material, take water as reaction solvent, described pyridoxine Pyridoxine or pyridoxine hydrochloride are selectively oxidized in water under the effect of a catalytic oxidation system to prepare pyridoxal or pyridoxal hydrochloride shown in formula (I);

Figure BDA0000124941240000021
Figure BDA0000124941240000021

所述的催化氧化体系包括氧源、催化剂、无机盐和胺类配体;The catalytic oxidation system includes an oxygen source, a catalyst, an inorganic salt and an amine ligand;

所述的氧源选自下列之一:空气,氧气,双氧水;The oxygen source is selected from one of the following: air, oxygen, hydrogen peroxide;

所述的催化剂选自下列一种或任意几种的组合:2,2,6,6-四甲基哌啶-氮-氧自由基,4-羟基-2,2,6,6-四甲基哌啶-1-氧自由基,4-乙酰氨基-2,2,6,6-四甲基哌啶-1-氮氧自由基,4-氨基-2,2,6,6-四甲基哌啶-1-氧自由基;The catalyst is selected from one or any combination of the following: 2,2,6,6-tetramethylpiperidine-nitrogen-oxygen free radical, 4-hydroxyl-2,2,6,6-tetramethyl Piperidine-1-oxyl radical, 4-acetamido-2,2,6,6-tetramethylpiperidin-1-nitroxyl radical, 4-amino-2,2,6,6-tetramethyl Piperidin-1-oxyl radical;

所述的无机盐选自下列一种或任意几种的组合:硝酸铜,硫酸铜,三氟甲磺酸铜,硫化铜,醋酸铜,溴化铜,溴化亚铜,碘化铜,碘化亚铜,氯化铜,氯化亚铜;The inorganic salt is selected from one or any combination of the following: copper nitrate, copper sulfate, copper trifluoromethanesulfonate, copper sulfide, copper acetate, copper bromide, cuprous bromide, copper iodide, iodine Cuprous chloride, cupric chloride, cuprous chloride;

所述的胺类配体选自下列一种或任意几种的组合:1,2-乙二胺,叔丁胺,二乙胺,三乙胺,三叔丁基胺,三正丁胺,1,4-二氮杂二环[2.2.2]辛烷,吗啡啉,吡啶,2-氨基吡啶,4-二甲氨基吡啶,4,6-二甲基-2-吡啶胺,氨水,氯化铵,硫酸铵,碳酸铵,碳酸氢铵,2,2′-联吡啶,4-异丙基吡啶,4-羟基吡啶。The amine ligand is selected from one or any combination of the following: 1,2-ethylenediamine, tert-butylamine, diethylamine, triethylamine, tri-tert-butylamine, tri-n-butylamine, 1, 4-diazabicyclo[2.2.2]octane, morpholine, pyridine, 2-aminopyridine, 4-dimethylaminopyridine, 4,6-dimethyl-2-pyridinamine, ammonia water, ammonium chloride , ammonium sulfate, ammonium carbonate, ammonium bicarbonate, 2,2'-bipyridine, 4-isopropylpyridine, 4-hydroxypyridine.

本发明在反应过程中,吡哆醛和盐酸吡哆醛处于化学平衡,故制备盐酸吡哆醛实际就是制备吡哆醛。In the reaction process of the present invention, pyridoxal and pyridoxal hydrochloride are in chemical equilibrium, so preparing pyridoxal hydrochloride is actually preparing pyridoxal.

本发明中,所述的选择性氧化在催化氧化体系的作用下进行,所述的催化氧化体系优选由氧源、催化剂、无机盐和胺类配体组成。In the present invention, the selective oxidation is carried out under the action of a catalytic oxidation system, and the catalytic oxidation system is preferably composed of an oxygen source, a catalyst, an inorganic salt and an amine ligand.

本发明中,当所述的氧源为空气或氧气时,所述空气或氧气的压力为1~5个大气压,优选为1~2个大气压。当所述的氧源为双氧水时,所述双氧水的用量以H2O2的摩尔数计为吡哆醇或盐酸吡哆醇的摩尔数的0.5~8倍,优选为1~2倍。In the present invention, when the oxygen source is air or oxygen, the pressure of the air or oxygen is 1-5 atmospheres, preferably 1-2 atmospheres. When the oxygen source is hydrogen peroxide, the amount of hydrogen peroxide used is 0.5 to 8 times, preferably 1 to 2 times, the moles of pyridoxine or pyridoxine hydrochloride based on the moles of H 2 O 2 .

本发明所述的催化剂为氮氧自由基,所述催化剂的用量以摩尔数计为吡哆醇或盐酸吡哆醇的摩尔数的0.01~5倍,优选为0.05~3倍。The catalyst described in the present invention is a nitroxide free radical, and the amount of the catalyst used is 0.01-5 times, preferably 0.05-3 times, the mole number of pyridoxine or pyridoxine hydrochloride in terms of moles.

本发明所述的无机盐为铜盐或亚铜盐,优选无机盐为下列之一:溴化铜,碘化铜,氯化铜,硝酸铜。本发明中,所述无机盐的用量以摩尔数计为吡哆醇或盐酸吡哆醇的摩尔数的0.01~3倍,优选为0.01~1倍,更优选为0.01~0.5倍。The inorganic salt described in the present invention is copper salt or cuprous salt, preferably the inorganic salt is one of the following: copper bromide, copper iodide, copper chloride, copper nitrate. In the present invention, the molar amount of the inorganic salt is 0.01-3 times, preferably 0.01-1 times, more preferably 0.01-0.5 times the moles of pyridoxine or pyridoxine hydrochloride.

本发明所述的胺类配体优选自下列之一:4-二甲氨基吡啶,4-羟基吡啶,氨水,氯化铵,三乙胺。本发明中,所述胺类配体的用量以摩尔数计为吡哆醇或盐酸吡哆醇的摩尔数的0.01~5倍,优选为0.01~1倍。The amine ligands described in the present invention are preferably selected from one of the following: 4-dimethylaminopyridine, 4-hydroxypyridine, ammonia water, ammonium chloride, and triethylamine. In the present invention, the molar amount of the amine ligand used is 0.01-5 times, preferably 0.01-1 times, the molar number of pyridoxine or pyridoxine hydrochloride.

本发明中,所述的选择性氧化在0~55℃的温度条件下进行。优选的,所述的选择性氧化在10~30℃的温度条件下进行。In the present invention, the selective oxidation is carried out at a temperature of 0-55°C. Preferably, the selective oxidation is carried out at a temperature of 10-30°C.

本发明可采用常规方法(比如液相色谱)监测反应终点,一般反应时间在1~2h。In the present invention, conventional methods (such as liquid chromatography) can be used to monitor the reaction end point, and the general reaction time is 1-2 hours.

本发明在选择性氧化完成后,通过柱层析可获得吡哆醛或盐酸吡哆醛。但是由于吡哆醛和盐酸吡哆醛不稳定,难分离,故在实际应用中,选择性氧化完成后所得反应液不经分离加入对乙氧基苯胺反应,得到相对应的Schiff碱(Ⅸ),此Schiff碱性质稳定,可供后续反应。具体操作可查考Masaru Iwanami发表的论文ANew Synthesis of Pyridoxal-5-phosphate,Vol.41,1968:161-165。In the present invention, after the selective oxidation is completed, pyridoxal or pyridoxal hydrochloride can be obtained by column chromatography. But because pyridoxal and pyridoxal hydrochloride are unstable and difficult to separate, so in practical applications, the reaction solution obtained after the selective oxidation is completed is not separated and added to p-ethoxyaniline for reaction to obtain the corresponding Schiff base (IX) , the Schiff base is stable in nature and can be used for subsequent reactions. For specific operations, please refer to the paper ANew Synthesis of Pyridoxal-5-phosphate, Vol.41, 1968: 161-165 published by Masaru Iwanami.

Figure BDA0000124941240000041
Figure BDA0000124941240000041

与现有技术相比,本发明所述的制备吡哆醛或盐酸吡哆醛的方法具有如下优势:转化率高,选择性好,反应条件温和,操作方便,成本低廉,对环境友好,具有良好的工业化应用价值。Compared with the prior art, the method for preparing pyridoxal or pyridoxal hydrochloride of the present invention has the following advantages: high conversion rate, good selectivity, mild reaction conditions, convenient operation, low cost, environmental friendliness, and Good industrial application value.

(四)具体实施方式(4) Specific implementation methods

以下以具体实施例来说明本发明的技术方案,但本发明的保护范围不限于此:The technical scheme of the present invention is described below with specific examples, but protection scope of the present invention is not limited thereto:

实施例1Example 1

在带有搅拌器和温度计的25mL反应瓶中,依次加入0.085g(0.5mmol)2,2,6,6-四甲基哌啶-氮-氧自由基,0.29g(2mmol)溴化铜,0.40g(5mmol)吡啶和2.06g(10mmol)盐酸吡哆醇。加入水5mL,温度控制在30℃,开启搅拌。然后滴加2.0g(18mmol)30%双氧水,同时控制反应温度在30~35℃。滴加完毕后,保温在30~35℃继续搅拌1~2小时,所得反应液经液相检测吡哆醇转化率达99%(液相条件:色谱柱为XDB-G8 250×4.6mm 5um。流动相为甲醇∶buffer=15∶85;buffer:0.04%戊烷磺酸钠用冰醋酸调PH至3;检测波长为284nm),反应选择性为98%。In a 25mL reaction flask with a stirrer and a thermometer, add 0.085g (0.5mmol) 2,2,6,6-tetramethylpiperidine-nitrogen-oxygen radical, 0.29g (2mmol) copper bromide successively, 0.40g (5mmol) pyridine and 2.06g (10mmol) pyridoxine hydrochloride. Add 5 mL of water, control the temperature at 30°C, and start stirring. Then 2.0 g (18 mmol) of 30% hydrogen peroxide was added dropwise while controlling the reaction temperature at 30-35° C. After the dropwise addition, keep stirring at 30-35° C. for 1-2 hours, and the obtained reaction solution has a pyridoxine conversion rate of 99% through liquid phase detection (liquid phase conditions: chromatographic column is XDB-G8 250×4.6mm 5um. The mobile phase is methanol: buffer=15:85; buffer: 0.04% sodium pentanesulfonate and adjust the pH to 3 with glacial acetic acid; the detection wavelength is 284nm), and the reaction selectivity is 98%.

另外,取约5mL反应液直接上硅胶柱,洗脱剂为二氯甲烷∶甲醇=20∶1,经梯度洗脱得最终洗脱液,浓缩至干,可得到白色固体盐酸吡哆醛,熔点164.1-164.8℃,核磁表征如下:1HNMR(400MHz,DMSO),δ:8.27(s,1H,CHO),6.63(d,1H,CH),5.00-5.16(m,2H,CH2),2.62(s,3H,CH3)。In addition, take about 5mL of the reaction solution and put it directly on the silica gel column, the eluent is dichloromethane:methanol=20:1, the final eluent is obtained by gradient elution, and concentrated to dryness to obtain pyridoxal hydrochloride as a white solid, melting point 164.1-164.8°C, NMR characteristics are as follows: 1 HNMR (400MHz, DMSO), δ: 8.27 (s, 1H, CHO), 6.63 (d, 1H, CH), 5.00-5.16 (m, 2H, CH 2 ), 2.62 (s, 3H, CH3 ).

由于盐酸吡哆醛不稳定,难分离,在实际应用中查考Masaru Iwanami发表的论文[A NewSynthesis of Pyridoxal-5-phosphate,Vol.41,1968:161-165],反应液不经分离接着加入对乙氧基苯胺1.37g(10mmol),经处理得到黄色Schiff碱(Ⅸ)2.10g。两步反应的总收率为88%。Since pyridoxal hydrochloride is unstable and difficult to separate, in practical applications, check the paper published by Masaru Iwanami [A NewSynthesis of Pyridoxal-5-phosphate, Vol.41, 1968: 161-165], the reaction solution is not separated and then added to the 1.37 g (10 mmol) of ethoxyaniline was treated to obtain 2.10 g of yellow Schiff base (IX). The overall yield of the two-step reaction was 88%.

实施例2Example 2

氧源改为1个大气压的氧气,无机盐换成1.5g(10mmol)硝酸铜,胺类配体换成1.0g(10mmol)三乙胺,其他操作同实施例1,得到黄色固体2.21g。液相检测吡哆醇转化率达99%,反应选择性为97%。两步反应的总收率为89%。The oxygen source was changed to 1 atmosphere of oxygen, the inorganic salt was changed to 1.5g (10mmol) copper nitrate, the amine ligand was changed to 1.0g (10mmol) triethylamine, and other operations were the same as in Example 1 to obtain 2.21g of a yellow solid. The conversion rate of pyridoxine is up to 99% and the reaction selectivity is 97% according to liquid phase detection. The overall yield of the two-step reaction was 89%.

实施例3Example 3

氧源改为2个大气压的氧气,无机盐换成0.29g(2mmol)溴化亚铜,胺类配体换成0.24g(4mmol)1,2-乙二胺,其他操作同实施例1,得到黄色固体1.90g。液相检测吡哆醇转化率达87%,反应选择性为95%。两步反应的总收率为74%。The oxygen source is changed into oxygen at 2 atmospheric pressures, the inorganic salt is changed into 0.29g (2mmol) cuprous bromide, and the amine ligand is changed into 0.24g (4mmol) 1,2-ethylenediamine, and other operations are the same as in Example 1, 1.90 g of a yellow solid was obtained. The conversion rate of pyridoxine is up to 87% and the reaction selectivity is 95% according to liquid phase detection. The overall yield of the two-step reaction was 74%.

实施例4Example 4

催化剂换为0.17g(1mmol)4-氨基-2,2,6,6-四甲基哌啶-1-氧自由基,30%双氧水改为0.55g(5mmol),无机盐换成0.095g(0.5mmol)碘化铜,胺类配体换成0.24g(5mmol)35%氨水,其他操作同实施例1,得到黄色固体2.07g。液相检测吡哆醇转化率达91%,反应选择性为95%。两步反应的总收率为80%。Catalyst is changed into 0.17g (1mmol) 4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl free radical, 30% hydrogen peroxide is changed into 0.55g (5mmol), and inorganic salt is changed into 0.095g ( 0.5mmol) copper iodide, the amine ligand was replaced with 0.24g (5mmol) 35% ammonia water, and other operations were the same as in Example 1 to obtain 2.07g of a yellow solid. The conversion rate of pyridoxine was detected by liquid phase to reach 91%, and the reaction selectivity was 95%. The overall yield of the two-step reaction was 80%.

实施例5Example 5

催化剂换为0.09g(0.5mmol)4-氨基-2,2,6,6-四甲基哌啶-1-氧自由基,30%双氧水改为2.8g(25mmol),无机盐换成0.20g(2mmol)氯化铜,胺类配体换成1.4g(16mmol)吗啡啉,其他操作同实施例1,得到黄色固体2.29g。液相检测吡哆醇转化率达98%,反应选择性为96%。两步反应的总收率为86%。The catalyst is changed to 0.09g (0.5mmol) 4-amino-2,2,6,6-tetramethylpiperidine-1-oxygen free radical, 30% hydrogen peroxide is changed to 2.8g (25mmol), and the inorganic salt is changed to 0.20g (2mmol) cupric chloride, the amine ligand is changed into 1.4g (16mmol) morpholine, other operation is the same as embodiment 1, obtains yellow solid 2.29g. The conversion rate of pyridoxine is up to 98% and the reaction selectivity is 96% according to liquid phase detection. The overall yield of the two-step reaction was 86%.

实施例6Example 6

催化剂换为0.086g(0.5mmol)4-羟基-2,2,6,6-四甲基哌啶-1-氧自由基,氧源改为一个大气压的空气,无机盐换成1.0(5mmol)醋酸铜,胺类配体换成1.3g(7mmol)三正丁胺,反应温度改为0~5℃,其他操作同实施例1,得到黄色固体1.93g。液相检测吡哆醇转化率达85%,反应选择性为95%。两步反应的总收率为72%。The catalyst is changed to 0.086g (0.5mmol) 4-hydroxyl-2,2,6,6-tetramethylpiperidine-1-oxyl radical, the oxygen source is changed to air at an atmospheric pressure, and the inorganic salt is changed to 1.0 (5mmol) Copper acetate, the amine ligand was replaced by 1.3g (7mmol) tri-n-butylamine, the reaction temperature was changed to 0-5°C, and other operations were the same as in Example 1 to obtain 1.93g of a yellow solid. The conversion rate of pyridoxine is up to 85% and the reaction selectivity is 95% according to liquid phase detection. The overall yield of the two-step reaction was 72%.

实施例7Example 7

催化剂换为0.86g(5mmol)4-羟基-2,2,6,6-四甲基哌啶-1-氧自由基,30%双氧水改为1.4g(12mmol),0.15g(1mmol)溴化铜,胺类配体换为0.095(1mmol)4-羟基吡啶,反应温度改为30~35℃,其他操作同实施例1,得到黄色固体2.05g。液相检测吡哆醇转化率达92%,反应选择性为96%。两步反应的总收率为81%。Catalyst is changed into 0.86g (5mmol) 4-hydroxyl-2,2,6,6-tetramethylpiperidine-1-oxyl radical, 30% hydrogen peroxide is changed into 1.4g (12mmol), 0.15g (1mmol) brominated Copper, the amine ligand was changed to 0.095 (1 mmol) 4-hydroxypyridine, the reaction temperature was changed to 30-35° C., and other operations were the same as in Example 1 to obtain 2.05 g of a yellow solid. The conversion rate of pyridoxine was detected by liquid phase to reach 92%, and the reaction selectivity was 96%. The overall yield of the two-step reaction was 81%.

实施例8Example 8

催化剂换成0.16g(0.8mmol)4-乙酰氨基-2,2,6,6-四甲基哌啶-1-氮氧自由基,氧源改为1个大气压的氧气,无机盐换成0.29g(2mmol)硝酸铜,胺类配体换为1.2g(12mmol)三乙胺,其他操作同实施例1,得到黄色固体2.10g。液相检测吡哆醇转化率达99%,反应选择性为92%。两步反应的总收率为84%。The catalyst was changed to 0.16g (0.8mmol) 4-acetylamino-2,2,6,6-tetramethylpiperidine-1-nitrogen radical, the oxygen source was changed to 1 atmospheric pressure of oxygen, and the inorganic salt was changed to 0.29 g (2mmol) copper nitrate, the amine ligand was replaced with 1.2g (12mmol) triethylamine, and other operations were the same as in Example 1 to obtain 2.10g of a yellow solid. The conversion rate of pyridoxine is up to 99% and the reaction selectivity is 92% according to liquid phase detection. The overall yield of the two-step reaction was 84%.

实施例9Example 9

催化剂换成3.0g(15mmol)4-乙酰氨基-2,2,6,6-四甲基哌啶-1-氮氧自由基,30%双氧水改为1.4g(12mmol),无机盐换成2.6g(18mmol)溴化亚铜,胺类配体换为0.98(8mmol)4-二甲氨基吡啶,其他操作同实施例1,得到黄色固体1.95g。液相检测吡哆醇转化率达86%,反应选择性为97%。两步反应的总收率为75%。The catalyst is changed to 3.0g (15mmol) 4-acetylamino-2,2,6,6-tetramethylpiperidine-1-nitrogen free radical, 30% hydrogen peroxide is changed to 1.4g (12mmol), and the inorganic salt is changed to 2.6 g (18 mmol) of cuprous bromide, the amine ligand was replaced with 0.98 (8 mmol) of 4-dimethylaminopyridine, and other operations were the same as in Example 1 to obtain 1.95 g of a yellow solid. The conversion rate of pyridoxine is up to 86% and the reaction selectivity is 97% according to liquid phase detection. The overall yield of the two-step reaction was 75%.

实施例10Example 10

催化剂换为4.3g(25mmol)2,2,6,6-四甲基哌啶-氮-氧自由基,30%双氧水改为2.3g(20mmol),无机盐换成0.38g(2mmol)碘化铜,胺类配体换成0.009g(0.1mmol)吗啡啉,其他操作同实施例1,得到黄色固体2.05g。液相检测吡哆醇转化率达93%,反应选择性为99%。两步反应的总收率为85%。Catalyst is changed into 4.3g (25mmol) 2,2,6,6-tetramethylpiperidine-nitrogen-oxygen free radical, 30% hydrogen peroxide is changed into 2.3g (20mmol), inorganic salt is changed into 0.38g (2mmol) iodide Copper, amine ligands were replaced by 0.009g (0.1mmol) morpholine, and other operations were the same as in Example 1 to obtain 2.05g of a yellow solid. The conversion rate of pyridoxine is up to 93% and the reaction selectivity is 99% according to liquid phase detection. The overall yield of the two-step reaction was 85%.

实施例11Example 11

催化剂换为4.7g(30mmol)2,2,6,6-四甲基哌啶-氮-氧自由基,无机盐换成0.20g(2mmol)氯化铜,胺类配体换成1.9g(10mmol)三正丁胺,其他操作同实施例1,得到黄色固体2.02g。液相检测吡哆醇转化率达90%,反应选择性为95%。两步反应的总收率为76%。Catalyst is changed into 4.7g (30mmol) 2,2,6,6-tetramethylpiperidine-nitrogen-oxygen free radical, inorganic salt is changed into 0.20g (2mmol) cupric chloride, and amine ligand is changed into 1.9g ( 10mmol) tri-n-butylamine, and other operations were the same as in Example 1 to obtain 2.02g of a yellow solid. The conversion rate of pyridoxine is up to 90% and the reaction selectivity is 95% according to liquid phase detection. The overall yield of the two-step reaction was 76%.

Claims (9)

1.一种吡哆醛或盐酸吡哆醛的制备方法,所述制备方法包括:以式(Ⅲ)所示的吡哆醇或盐酸吡哆醇为初始原料,以水为反应溶剂,所述的吡哆醇或盐酸吡哆醇在水中在催化氧化体系的作用下选择性氧化制得式(Ⅰ)所示的吡哆醛或盐酸吡哆醛;所述的选择性氧化在0~55℃的温度条件下进行;1. a preparation method of pyridoxal or pyridoxal hydrochloride, said preparation method comprising: taking pyridoxine or pyridoxine hydrochloride shown in formula (Ⅲ) as initial raw material, taking water as reaction solvent, said Pyridoxine or pyridoxine hydrochloride are selectively oxidized in water under the action of a catalytic oxidation system to prepare pyridoxal or pyridoxal hydrochloride shown in formula (I); the selective oxidation is performed at 0-55°C under temperature conditions; 所述的催化氧化体系包括氧源、催化剂、无机盐和胺类配体;The catalytic oxidation system includes an oxygen source, a catalyst, an inorganic salt and an amine ligand; 所述的氧源选自下列之一:空气,氧气,双氧水;The oxygen source is selected from one of the following: air, oxygen, hydrogen peroxide; 所述的催化剂选自下列一种或任意几种的组合:2,2,6,6-四甲基哌啶-氮-氧自由基,4-羟基-2,2,6,6-四甲基哌啶-1-氧自由基,4-乙酰氨基-2,2,6,6-四甲基哌啶-1-氮氧自由基,4-氨基-2,2,6,6-四甲基哌啶-1-氧自由基;The catalyst is selected from one or any combination of the following: 2,2,6,6-tetramethylpiperidine-nitrogen-oxygen free radical, 4-hydroxyl-2,2,6,6-tetramethyl Piperidin-1-oxyl radical, 4-acetamido-2,2,6,6-tetramethylpiperidin-1-nitroxyl radical, 4-amino-2,2,6,6-tetramethyl Piperidin-1-oxyl radical; 所述的无机盐选自下列一种或任意几种的组合:硝酸铜,硫酸铜,醋酸铜,溴化铜,溴化亚铜,碘化铜,碘化亚铜,氯化铜,氯化亚铜;The inorganic salt is selected from one or any combination of the following: copper nitrate, copper sulfate, copper acetate, copper bromide, cuprous bromide, copper iodide, cuprous iodide, cupric chloride, chlorinated Cuprous; 所述的胺类配体选自下列一种或任意几种的组合:1,2-乙二胺,叔丁胺,二乙胺,三乙胺,三叔丁基胺,三正丁胺,1,4-二氮杂二环[2.2.2]辛烷,吗啡啉,吡啶,2-氨基吡啶,4-二甲氨基吡啶,4,6-二甲基-2-吡啶胺,氨水,2,2'-联吡啶,4-异丙基吡啶,4-羟基吡啶。The amine ligand is selected from one or any combination of the following: 1,2-ethylenediamine, tert-butylamine, diethylamine, triethylamine, tri-tert-butylamine, tri-n-butylamine, 1, 4-diazabicyclo[2.2.2]octane, morpholine, pyridine, 2-aminopyridine, 4-dimethylaminopyridine, 4,6-dimethyl-2-pyridinamine, ammonia, 2,2 '-bipyridine, 4-isopropylpyridine, 4-hydroxypyridine. 2.如权利要求1所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述的选择性氧化在10~30℃的温度条件下进行。2. the preparation method of pyridoxal or pyridoxal hydrochloride as claimed in claim 1 is characterized in that: described selective oxidation is carried out under the temperature condition of 10~30 ℃. 3.如权利要求1所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述的催化氧化体系由氧源、催化剂、无机盐和胺类配体组成。3. the preparation method of pyridoxal or pyridoxal hydrochloride as claimed in claim 1 is characterized in that: described catalytic oxidation system is made up of oxygen source, catalyzer, inorganic salt and amine ligand. 4.如权利要求1~3之一所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述吡哆醇或盐酸吡哆醇与催化剂、无机盐、胺类配体的摩尔比为1:0.01~5:0.01~3:0.01~5;并且所述的氧源为空气或氧气,所述空气或氧气的压力为1~5个大气压,或者所述的氧源为双氧水,所述吡哆醇或盐酸吡哆醇与H2O2的摩尔比为1:0.5~8。4. the preparation method of pyridoxal or pyridoxal hydrochloride as described in one of claim 1~3, it is characterized in that: described pyridoxine or pyridoxine hydrochloride and catalyzer, inorganic salt, amine ligand The molar ratio is 1:0.01~5:0.01~3:0.01~5; and the oxygen source is air or oxygen, and the pressure of the air or oxygen is 1 to 5 atmospheres, or the oxygen source is hydrogen peroxide , the molar ratio of pyridoxine or pyridoxine hydrochloride to H2O2 is 1:0.5-8. 5.如权利要求4所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述吡哆醇或盐酸吡哆醇与催化剂、无机盐、胺类配体的摩尔比为1:0.05~3:0.01~1:0.01~1;并且所述的氧源为空气或氧气,所述空气或氧气的压力为1~2个大气压,或者所述的氧源为双氧水,所述吡哆醇或盐酸吡哆醇与H2O2的摩尔比为1:1~2。5. the preparation method of pyridoxal as claimed in claim 4 or pyridoxal hydrochloride is characterized in that: the mol ratio of described pyridoxine or pyridoxine hydrochloride and catalyzer, inorganic salt, amine ligand is 1 : 0.05~3: 0.01~1: 0.01~1; and the oxygen source is air or oxygen, and the pressure of the air or oxygen is 1 to 2 atmospheres, or the oxygen source is hydrogen peroxide, and the pyridine The molar ratio of pyridoxine or pyridoxine hydrochloride to H2O2 is 1:1~2. 6.如权利要求4所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述无机盐选自下列一种:溴化铜,碘化铜,氯化铜,硝酸铜。6. the preparation method of pyridoxal as claimed in claim 4 or pyridoxal hydrochloride is characterized in that: described inorganic salt is selected from following one: copper bromide, copper iodide, cupric chloride, cupric nitrate. 7.如权利要求5所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述无机盐选自下列一种:溴化铜,碘化铜,氯化铜,硝酸铜。7. the preparation method of pyridoxal as claimed in claim 5 or pyridoxal hydrochloride is characterized in that: described inorganic salt is selected from following one: copper bromide, copper iodide, cupric chloride, cupric nitrate. 8.如权利要求6或7所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述的胺类配体选自下列之一:4-二甲氨基吡啶,4-羟基吡啶,氨水,三乙胺。8. The preparation method of pyridoxal or pyridoxal hydrochloride as claimed in claim 6 or 7, is characterized in that: described amine ligand is selected from one of following: 4-dimethylaminopyridine, 4-hydroxyl Pyridine, ammonia, triethylamine. 9.如权利要求1所述的吡哆醛或盐酸吡哆醛的制备方法,其特征在于:所述制备方法还包括如下步骤:在选择性氧化完成后,所得反应液不经分离直接加入对乙氧基苯胺,反应得到式(Ⅸ)所示的Schiff碱,所述吡哆醛或盐酸吡哆醛以Schiff碱的形式保存,9. the preparation method of pyridoxal as claimed in claim 1 or pyridoxal hydrochloride is characterized in that: described preparation method also comprises the steps: after selective oxidation is finished, gained reaction solution directly adds to Ethoxyaniline, reaction obtains the Schiff base shown in formula (IX), and described pyridoxal or pyridoxal hydrochloride are preserved with the form of Schiff base,
Figure FDA0000460216460000021
Figure FDA0000460216460000021
CN201110442237.1A 2011-12-26 2011-12-26 Preparation method of pyridoxal or pyridoxal hydrochloride Active CN102617455B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110442237.1A CN102617455B (en) 2011-12-26 2011-12-26 Preparation method of pyridoxal or pyridoxal hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110442237.1A CN102617455B (en) 2011-12-26 2011-12-26 Preparation method of pyridoxal or pyridoxal hydrochloride

Publications (2)

Publication Number Publication Date
CN102617455A CN102617455A (en) 2012-08-01
CN102617455B true CN102617455B (en) 2014-06-04

Family

ID=46557720

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110442237.1A Active CN102617455B (en) 2011-12-26 2011-12-26 Preparation method of pyridoxal or pyridoxal hydrochloride

Country Status (1)

Country Link
CN (1) CN102617455B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106117129B (en) * 2016-06-23 2019-05-07 江苏理工学院 A kind of preparation method of pyridoxal
CN108976259A (en) * 2017-06-01 2018-12-11 上海凯赛生物技术研发中心有限公司 A kind of synthetic method of phosphopyridoxal pyridoxal phosphate
CN107236770A (en) * 2017-06-28 2017-10-10 武汉科技大学 A kind of chemical and bio combined method for catalyzing and synthesizing phosphopyridoxal pyridoxal phosphate
CN107382838B (en) * 2017-08-08 2019-11-19 东瑞(南通)医药科技有限公司 A kind of preparation method of phosphopyridoxal pyridoxal phosphate intermediate
CN111517902B (en) * 2019-02-01 2022-06-14 清华大学 Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072309A2 (en) * 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
WO2002004421A2 (en) * 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) * 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
CN101628892A (en) * 2009-08-09 2010-01-20 常熟富士莱医药化工有限公司 Preparation method of pyridoxamine dihydrochloride

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072309A2 (en) * 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
WO2002004421A2 (en) * 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) * 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
CN101628892A (en) * 2009-08-09 2010-01-20 常熟富士莱医药化工有限公司 Preparation method of pyridoxamine dihydrochloride

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Ru(III)-catalyzed oxidation of pyridoxine and albuterol in pharmaceuticals;More Ashok,等;《Spectrochimica Acta Part A: Molecular andBiomolecular Spectroscopy》;20080803;第72卷(第1期);第204-208页 *
超声波催化二氧化锰氧化吡哆醇为吡哆醛的简便方法;何地平,等;《陕西师范大学学报自然科学版》;20040630;第32卷(第2期);第61-63页 *

Also Published As

Publication number Publication date
CN102617455A (en) 2012-08-01

Similar Documents

Publication Publication Date Title
Hu et al. Visible light induced hydrodifluoromethylation of alkenes derived from oxindoles with (difluoromethyl) triphenylphosphonium bromide
CN107188834B (en) The preparation method of 2-aryl-vinylsulfonyl fluoride compound
CN106117216B (en) A kind of method of atmospheric synthesis 6H- iso-indoles [2,1-a] indoles -6- ketone compounds
Karthikeyan et al. A novel CuCl2/BIL catalyst for direct oxidation of alcohol to acid at ambient temperature
CN106977572A (en) A kind of method using hyodesoxycholic acid as Material synthesis lithocholic acid
CN102617455A (en) Preparation method of pyridoxal or pyridoxal hydrochloride
CN103664896A (en) Synthetic process method for novel antineoplastic molecular targeted drug of crizotinib
CN110272403B (en) Method for synthesizing carbamate containing dihydrobenzofuran ring and trifluoromethyl
CN108864164B (en) Synthesis method of primary amine-guided 2-alkynyl indole compound
CN109867694A (en) A kind of synthetic method of the 7- alkynyl Benzazole compounds of oxygen guiding
CN109422683A (en) A method of synthesis 6- aldehyde radical phenanthridines class compound and its derivative
CN105669686B (en) A kind of synthetic method of 6- (tertbutyloxycarbonyl) octahydros furans [2,3-c] Pyridine-4-carboxylic acid
CN106892928A (en) A kind of synthetic method of the carboxylate of 8 hydroxyl of the tert-butyl group, 5 oxa- 2 azaspiro [3.5] nonane 2
CN103086852A (en) Novel method for preparing 6,6-dimethylbicycol[3.1.1]heptane-2, 3-dione
CN104045643A (en) Method for preparing pyrazolo [1, 5-c] quinazoline skeleton compounds by copper catalysis in water phase
CN104591938B (en) Synthetic method of pharmaceutical intermediate diarylmethane compound
CN105153152B (en) A kind of synthetic method of imidazoles fused ring compound
CN110483494B (en) Chiral bisoxazoline-hydrogenated imidazolium carbene salt compound, its synthesis method and application
CN105198791A (en) Synthetic method of medicine intermediate aza spiro compound
CN104262295B (en) The synthetic method of a kind of epoxy chalcone and derivative thereof
CN104447528B (en) The preparation method of pyridine-2,3-diethyl dicarboxylate
CN105601639B (en) A kind of 6- tertbutyloxycarbonyls octahydro -2H- pyrans [3,2-c] and the synthetic method of pyridine -8- carboxylic acids
CN107056781A (en) A kind of synthetic method of the formaldoxime of (E) 5 methyl 1H pyrrolo-es [2,3 b] pyridine 3
CN105153045B (en) A kind of synthetic method of pharmaceutical intermediate quinazoline derivant
CN102516253A (en) Method for synthesizing 3,4-dihydro-2H-pyrano[3,2-b]pyridine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20171225

Address after: Hangzhou City, Zhejiang province 310014 City Zhaohui District Six

Co-patentee after: Jiangxi Tianxin pharmaceutical Limited by Share Ltd

Patentee after: Zhejiang University of Technology

Address before: 310014 Hangzhou city in the lower reaches of the city of Zhejiang Wang Road, No. 18

Co-patentee before: Zhejiang Tianxin Pharmaceuticals Co.,Ltd.

Patentee before: Zhejiang University of Technology